Phase II trial of nitric oxide in patients with respiratory syncytial virus and bronchiolitis
Phase of Trial: Phase II
Latest Information Update: 21 Apr 2015
At a glance
- Drugs Nitric oxide (Primary)
- Indications Bronchiolitis; Respiratory syncytial virus infections
- Focus Therapeutic Use
- 21 Apr 2015 Data will be presented at the American Thoracic Society 2015 International Conference, according to an Advanced Inhalation Therapies media release.
- 21 Apr 2015 Updated data will be presented at the European Society of Pediatric Infectious Disease 2015, according to a Advanced Inhalation Therapies media release.
- 07 Jan 2014 This trial is continuing, according to an AIT media release.